Suchergebnisse - "Allegretti, Jessica R"

PubPharm (197)

61

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

ErratumIn: BMC Gastroenterol. 2022 Jul 26;22(1):356. - PMID 35883049

62

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

63

Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

enthalten in: Inflammatory bowel diseases | 2022

von Hassan-Zahraee, M. | Ye, Z. | Xi, L. | +20

64

Response to McFarland et al

enthalten in: The American journal of gastroenterology | 2022

von Kelly, C. | Fischer, M. | Allegretti, J. | +4

CommentOn: Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. - PMID 34003176

65

Correction to : ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

enthalten in: The American journal of gastroenterology | 2022

von Kelly, C. | Fischer, M. | Allegretti, J. | +4

ErratumFor: Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. - PMID 34003176

66

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Gupta, S. | Goodrick, H. | +2

67

Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Mullish, B. | Martinez‐Gili, L. | Chekmeneva, E. | +10

68

Gut Metabolites Predict Clostridioides Difficile Recurrence

enthalten in: ResearchSquare.com | 2021

von Dawkins, J. | Allegretti, J. | Gibson, T. | +4

69

Gut metabolites predict Clostridioides difficile recurrence

enthalten in: bioRxiv.org | 2021

von Dawkins, J. | Allegretti, J. | Gibson, T. | +4

70

Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated

enthalten in: Inflammatory bowel diseases | 2021

von Allegretti, J. | Canakis, A. | McClure, E. | +7